Martingale Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Martingale Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,921	Closed	-$946K	–	957
2020 Q4	$946K	Sell	12,921 -11,407	-47%	-$848K	0.01%	458
2020 Q3	$1.89M	Sell	24,328 -3,092	-11%	-$213K	0.02%	438
2020 Q2	$1.52M	Sell	27,420 -8,871	-24%	-$380K	0.02%	616
2020 Q1	$1.07M	Buy	36,291 +14,764	+69%	+$500K	0.01%	656
2019 Q4	$780K	Buy	21,527 +10,814	+101%	+$332K	0.01%	809
2019 Q3	$292K	Buy	+10,713	New	+$277K	﹤0.01%	937
2018 Q4	–	Sell	-52,055	Closed	-$1.02M	–	1054
2018 Q3	$1.02M	Sell	52,055 -24,106	-32%	-$458K	0.01%	729
2018 Q2	$1.26M	Sell	76,161 -24,811	-25%	-$378K	0.02%	693
2018 Q1	$1.43M	Hold	100,972	–	–	0.02%	641
2017 Q4	$1.48M	Buy	100,972 +526	+0.5%	+$7.39K	0.02%	621
2017 Q3	$1.27M	Buy	100,446 +33,200	+49%	+$422K	0.02%	674
2017 Q2	$799K	Buy	+67,246	New	+$836K	0.01%	754

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Martingale Asset Management's HZNP Position: Q1 2021 in Review

Martingale Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 12,921 shares — an estimated $946K sold.

Martingale Asset Management first reported a position in HZNP in Q2 2017 and held it in 12 quarters. The position peaked at $1.89M in Q3 2020. 517 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Martingale Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Martingale Asset Management sold 12,921 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $946K.
Martingale Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 12 quarters.
Martingale Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.89M in Q3 2020.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Martingale Asset Management's 13F filing for Q1 2021, filed 13 May 2021.